Treatment recommendations for stage I non-small cell lung cancer: does patient preference matter?

about

Treatment recommendations for stage I non-small cell lung cancer: does patient preference matter?

Item

http://www.wikidata.org/entity/Q47138383

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Treatment recommendations for ...... oes patient preference matter?

@en

Treatment recommendations for ...... oes patient preference matter?

@nl

type

Item

label

Treatment recommendations for ...... oes patient preference matter?

@en

Treatment recommendations for ...... oes patient preference matter?

@nl

prefLabel

Treatment recommendations for ...... oes patient preference matter?

@en

Treatment recommendations for ...... oes patient preference matter?

@nl

P1476

Treatment recommendations for ...... oes patient preference matter?

@en

P2093

David R Baldwin

http://www.w3.org/2001/XMLSchema#string

Helen A Powell

http://www.w3.org/2001/XMLSchema#string

P2860

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Power imbalance prevents shared decision making.

Relationship between Physicians' Uncertainty about Clinical Assessments and Patient-Centered Recommendations for Colorectal Cancer Screening in the Elderly.

Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis.

The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

Treatment recommendations by clinicians in stage I non-small cell lung cancer: A study of factors that influence the likelihood of accounting for the patient's preference.

Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries.

Patients' attitudes to risk in lung cancer surgery: A qualitative study.

Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: A binary choice experiment.

P304

411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/ATM.2017.08.01

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29152511

http://www.w3.org/2001/XMLSchema#string

P932

5673782

http://www.w3.org/2001/XMLSchema#string